MedTrace Logo

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin

NCT04448821 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-11-04

No results posted yet for this study

Summary

The aim of the study is to evaluate the effect of nilotinib on the pharmacokinetics and pharmacodynamics of metformin in healthy male adults

Conditions

  • Healthy

Interventions

DRUG

Metformin

Single administration of metformin

DRUG

Metformin + Nilotinib

Coadministration of metformin and nilotinib

Sponsors & Collaborators

  • Hyewon Chung

    lead OTHER

Principal Investigators

  • Hyewon Chung, MD, PhD · Clinical Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-23
Primary Completion
2020-09-07
Completion
2020-09-07

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04448821 on ClinicalTrials.gov